Full text loading...
- ISSN: 1389-4501
- E-ISSN: 1873-5592
-
Anti-VEGF and Retinal Dystrophies
- Source: Current Drug Targets, Volume 21, Issue 12, Sep 2020, p. 1201 - 1207
-
- 01 Sep 2020
Abstract
The therapeutic approach based on anti-vascular endothelial growth factor (anti-VEGF) molecules can be used to treat two important complications of retinal dystrophies: choroidal neovascularization and macular edema. The macular involvement in retinal dystrophies can lead to further visual deterioration in patients at a young age and already affected by functional limitations. The study reports the effect of anti-VEGF treatment in several subforms of retinal dystrophies, critically discussing advantages and limitations.
© Bentham Science Publishers